Pattern of psychotropic prescription in a tertiary care center: A critical analysis

Indian Journal of Pharmacology

Volumn 45, Issue 3, 2013, Pages 270-273

  Sarkar, Pinaki ^a   Chakraborty, Kaustav ^a   Misra, Ajaya ^b   Shukla, Rajnikant ^b   Swain, Sarada Prasanna ^b  

^a CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

^b Department of Obstetrics and Gynaecology   (India)

Author keywords

Polypharmacy; prescription patterns; psychotropics

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; CHECKLIST; CHILD PSYCHIATRY; COMORBIDITY; CONSULTATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; MONOTHERAPY; MOOD DISORDER; ORGANIC PSYCHOSYNDROME; POLYPHARMACY; PREDICTIVE VALUE; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SUBSTANCE ABUSE; TERTIARY HEALTH CARE;

POLYPHARMACY; PRESCRIPTION PATTERNS; PSYCHOTROPICS;

ADOLESCENT; ADULT; AGED; DRUG UTILIZATION; FEMALE; HUMANS; INDIA; MALE; MENTAL DISORDERS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PSYCHOTROPIC DRUGS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84878512829     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.111947     Document Type: Article

References (16)

1. Edlinger M, Hausmann A, Kemmler G, Kurz M, Kurzthaler I, Walch T, et al. Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period. Schizophr Res 2005;77:25-34.
2. Stahl SM. Antipsychotic polypharmacy: Evidence based or eminence based? Acta Psychiatr Scand 2002;106:321-2.
3. Preskorn SH, Lacey RL. Polypharmacy: When is it rational? J Psychiatr Pract 2007;13:97-105.
4. McIntyre RS, Jerrell JM. Polypharmacy in children and adolescents treated for major depressive disorder: A claims database study. J Clin Psychiatry 2009;70:240-6.
5. Glezer A, Byatt N, Cook R Jr, Rothschild AJ. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic. J Affect Disord 2009;117:18-23.
6. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: A meta-analysis of randomized controlled trials. Schizophr Bull 2009;35:443-57.
7. Pandurangi AK, Dalkilic A. Polypharmacy with second-generation antipsychotics: A review of evidence. J Psychiatr Pract 2008;14:345-67.
8. Gardos G. Antipsychotic polypharmacy or monotherapy? Neuropsychopharmacol Hung 2005;7:72-7.
9. McMillan DA, Harrison PM, Rogers LJ, Tong N, McLean AJ. Polypharmacy in an Australian teaching hospital. Preliminary analysis of prevalence, types of drugs and associations. Med J Aust 1986;145:339-42.
10. Nolan L, O'Malley K. Prescribing for the elderly: Part II. Prescribing patterns: Differences due to age. J Am Geriatr Soc 1988;36:245-54.
11. De las Cuevas C, Sanz EJ. Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry 2004;4:18.
12. Trumic E, Pranjic N, Begic L, Becic F, Asceric M. Idiosyncratic adverse reactions of most frequent drug combinations longterm use among hospitalized patients with polypharmacy. Med Arh 2012;66:243-8.
13. Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 2012;69:476-83.
14. Stahl SM. Antipsychotic polypharmacy: Never say never, but never say always. Acta Psychiatr Scand 2012;125:349-51.
15. Kingsbury SJ, Yi D, Simpson GM. Psychopharmacology: Rational and irrational polypharmacy. Psychiatr Serv 2001;52:1033-6.
16. Murray MD, Kroenke K. Polypharmacy and medication adherence: Small steps on a long road. J Gen Intern Med 2001;16:137-9.